2024 Course Overview

The Gastrointestinal, Liver, and Pancreatic Pathology course provides a broad overview of many areas of gastrointestinal, pancreatic, and hepatobiliary pathology and is presented by Harvard Medical School faculty and selected guest faculty with recognized expertise in the topic areas. The course is designed to update both academic practicing pathologists and those in the community with advances in gastrointestinal, pancreatic, and hepatobiliary pathology, and to provide aids in diagnosis based on conventional morphologic analysis, as well as updates on new staging criteria, new techniques such as novel immunohistochemistry markers, and molecular pathology data. Interactive learning formats, including didactic lectures, case seminars, and frequent discussion periods with extensive time for contact with faculty will be provided. The course will assist the learners in developing new strategies they can use in practice, leading to improved diagnoses, and better patient care.

Who Should Attend

• Specialty Physicians
• Allied Health Professionals

Learning Objectives

Describe the spectrum of benign and neoplastic gastrointestinal, pancreatic and liver disorders with emphasis on use of proper and up-to date nomenclature and criteria, and reporting findings of prognostic significance which meet current practice standards.

Upon completion of this activity, participants will be able to:

• Evaluate gastrointestinal, pancreatic, and hepatobiliary cancers in the context of up-to-date grading and staging guidelines.
• Evaluate difficult GI lesions with a better understanding of the relevant histologic features of those lesions, as well as the techniques that add value in their assessment.
• Evaluate non-tumoral pathology of the GI tract and liver with a better understanding of the differential diagnosis, how to incorporate clinical information into that differential, and how to address the needs of clinical colleagues.

2024 Agenda

All agenda sessions are in Eastern Time.

Information for the 2025 course is not yet available.

Monday, May 6, 2024

Jonathan N. Glickman, MD, PhD; Mark Redston, MD

Introduction/Welcome

Mark Redston, MD

Barrett’s Esophagus and Associated Neoplasia

Kunal Jajoo, MD

Clinician’s Perspective- Upper GI Tract

Mark Redston, MD; Kunal Jajoo, MD

Q&A

Break

Stuti Shroff, MBBS, PhD

Gastric Polyps and Precursor Lesions

Jeffrey Goldsmith, MD

Celiac Disease and its Differential Diagnosis

Miranda Machacek, MD, PhD

Slide Seminar on Upper GI Tract

Jeffrey Goldsmith, MD; Miranda Machacek, MD, PhD; Stuti Shroff, MBBS, PhD

Q&A

Lunch

Mark Redston, MD

Biopsy Diagnosis of Colitis

Michael G. Drage, MD, PhD

IBD: Controversies and Challenges

Jonathan N. Glickman, MD, PhD

Colon Polyps and Polyposis

Mark Redston, MD; Michael G. Drage, MD, PhD; Jonathan N. Glickman, MD, PhD

Q&A

Break

Jonathan Nowak, MD, PhD

Molecular Diagnostics in Colon Cancer and Screening for Lynch Syndrome

Mark Redston, MD

Challenges in Colon Cancer Staging

Jonathan N. Glickman, MD, PhD

Slide Seminar: Lower GI

Jonathan Nowak, MD, PhD; Mark Redston, MD; Jonathan N. Glickman, MD, PhD

Q&A

Tuesday, May 7, 2024

Jason L. Hornick, MD, PhD

GIST: From KIT to Succinate Dehydrogenase

David Papke, MD, PhD

Mesenchymal Tumors and Mesenchymal Polyps (other than GIST)

Mari Mino-Kenudson, MD

Drug Induced Disorders of GI Tract

Mari Mino-Kenudson, MD; Jason L. Hornick, MD, PhD; David Papke, MD, PhD

Q&A

Break

Judith A. Ferry, MD

GI Lymphomas

Joseph Misdraji, MD

Appendiceal Mucinous Neoplasms

Jonathan N. Glickman, MD, PhD

Anal Pathology: Overview and Update

Judith A. Ferry, MD; Joseph Misdraji, MD; Jonathan N. Glickman, MD, PhD

Q&A

Lunch

Raul S. Gonzalez, MD

Endocrine Tumors of the Tubal Gut

Lisa Zhang, MD

Cytology and Small Biopsy Diagnosis of Pancreaticobiliary Tumors

Raul S. Gonzalez, MD; Lisa Zhang, MD

Q&A

Break

Mari Mino-Kenudson, MD

Surgical Pathology of Pancreatic Tumors

Stuti Shroff, MBBS, PhD

Biliary Tract Neoplasia

Esther Baranov, MD

Slide Seminar: Instructive Cases in Pancreatic Pathology

Mari Mino-Kenudson, MD; Stuti Shroff, MBBS, PhD; Esther Baranov, MD

Q&A

Wednesday, May 8, 2024

Angela Shih, MD

Medical Liver 1- Diagnostic Approach to Hepatitis

Lei Zhao, MD, PhD

Medical Liver 2- Fatty Liver

Daniel S. Pratt, MD

Clinician’s Perspective on Liver Biopsies

Angela Shih, MD; Lei Zhao, MD, PhD; Daniel S. Pratt, MD

Q&A

Break

Rondell Graham, MBBS

Liver Tumors

Angela Shih, MD

Medical Liver 3- Cholestatic Disorders

Lei Zhao, MD PhD

Case Seminar: Challenging Liver Cases

Lei Zhao, MD PhD; Angela Shih, MD; Rondell Graham, MBBS

Q&A

Jonathan N. Glickman, MD, PhD; Mark Redston, MD

Concluding Remarks

Course Adjourns